Drug Trial Radar · NCT06322394
BXOS110 Injection in the Treatment of Acute Ischaemic Stroke
Last checked: Nov 19, 2026Latest source record: Mar 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
300
Planned (sponsor's estimate)
Start
Feb 7, 2024
Primary completion
Mar 2025
Study completion Sep 2025
Sponsor
- Lead sponsor
- Biocells (Beijing) Biotech Co.,LtdIndustry
- Sponsor type
- Industry
- First posted
- Mar 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to evaluate the effectiveness of early administration of BXOS110 for injection in reducing overall disability in patients with acute ischaemic stroke.
Conditions
- Acute Ischemic Stroke
Interventions
high-dose BXOS110Drug
3.0 mg/kg, maximum dose not exceeding 300 mg,Participants received one administration by intravenous infusion.
low-dose BXOS110Drug
2.0 mg/kg, maximum dose not exceeding 200 mg,Participants received one administration by intravenous infusion.
PlaceboDrug
Does not contain any test drug active ingredients,Participants received one administration by intravenous infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects with mRS score 0-2 on day 90Time frame: Day 90
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Beijing Tiantan Hospital , Capital Medical University
Beijing, China · Not yet recruiting
Yuebei People's Hospital
Shaoguan, Guangdong, China · Not yet recruiting
Harrison International Peace Hospital
Hengshui, Hebei, China · Not yet recruiting
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Not yet recruiting
Daqing Oilfield General Hospital
Daqing, Heilongjiang, China · Not yet recruiting
Anyang People's Hospital
Anyang, Henan, China · Not yet recruiting
Nanshi Hospital of Nanyang
Nanyang, Henan, China · Not yet recruiting
Nanyang Second General Hospital
Nanyang, Henan, China · Not yet recruiting
The First Affiliated Hospital of Nanyang Medicinal College
Nanyang, Henan, China · Not yet recruiting
MeiHekou Central Hospital
Meihekou, Jilin, China · Not yet recruiting
Beipiao Central Hospital
Chaoyang, Liaoning, China · Recruiting
Ceneral Hospital of Mining Industry Group Fuxin
Fuxin, Liaoning, China · Not yet recruiting
The Affiliated Hospital of Shenyang Medical College
Shenyang, Liaoning, China · Not yet recruiting
The First People's Hospital of Shenyang
Shenyang, Liaoning, China · Not yet recruiting
The People's Hospital of Liaoning Province
Shenyang, Liaoning, China · Not yet recruiting
Iron Coal General Hospital of Liaoning Health Industry Group
Tieling, Liaoning, China · Not yet recruiting
Keshketengqi Hospital of Traditional Chinese Medicine and Mongolian Medicine
Chifeng, Neimenggu, China · Recruiting
Xianyang Hospital of Yan'an University
Xianyang, Shaanxi, China · Not yet recruiting
Liaocheng People's Hospital
Liaocheng, Shandong, China · Not yet recruiting
Linyi People's Hospital
Linyi, Shandong, China · Not yet recruiting
Tengzhou Central People's Hospital
Tengzhou, Shandong, China · Not yet recruiting
Sinopharm Tongmei General Hospital
Datong, Shanxi, China · Not yet recruiting
Linfen Central Hospital
Linfen, Shanxi, China · Recruiting
Linfen People's Hospital
Linfen, Shanxi, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.